Get the Stockscreener App
1.03
6.76%
-0.08
Shattuck Labs Inc stock is traded at $1.03, with a volume of 76,108.
It is down -6.76% in the last 24 hours and down -17.20% over the past month.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
See More
Previous Close:
$1.11
Open:
$1.11
24h Volume:
76,108
Relative Volume:
0.13
Market Cap:
$52.84M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.4747
EPS:
-2.17
Net Cash Flow:
$-70.93M
1W Performance:
-24.45%
1M Performance:
-17.20%
6M Performance:
-86.59%
1Y Performance:
-54.80%
1-Day Range:
$1.03
$1.14
1-Week Range:
$1.03
$1.45
52-Week Range:
$1.03
$11.76
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| STTK | 1.03 | 52.84M | 2.72M | -85.08M | -70.93M | -2.17 |
| VRTX | 447.95 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.58 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.60 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.33 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.59 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Shattuck Labs stock plunges to 52-week low at $1.06 - Investing.com
Citigroup Downgrades Shattuck Labs (STTK) - MSN
Shattuck Labs’ (STTK) Neutral Rating Reaffirmed at HC Wainwright - Defense World
Shattuck Labs Focuses on Promising Antibody Development - TipRanks
FY2024 EPS Estimates for Shattuck Labs Reduced by Analyst - MarketBeat
HC Wainwright Lowers Earnings Estimates for Shattuck Labs - Defense World
Shattuck Labs Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
STTK (Shattuck Labs) Degree of Operating Leverage : -0.01 (As of Jun. 2024) - GuruFocus.com
Shattuck Labs' (STTK) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat
Shattuck Labs sees cash runway into 2027 - Yahoo Finance
Shattuck Labs Inc (STTK) Quarterly 10-Q Report - Quartzy
Shattuck Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Shattuck Labs Inc (STTK) Q3 2024 Earnings: Revenue Soars to $3.0M, EPS Loss of $0.33 Beats Estimates - GuruFocus.com
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs Narrows Q3 Loss, Pivots Focus to SL-325 with $90.1M Cash Runway | STTK Stock News - StockTitan
Prosight Management, LP Expands Stake in Shattuck Labs Inc - GuruFocus.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc.STTK - PR Newswire
FMR LLC's Strategic Reduction in Shattuck Labs Inc Holdings - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Shattuck Labs Inc - GuruFocus.com
Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 60.0% in October - Defense World
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Shareholders to Connect - AccessWire
Shattuck Labs, Inc. (NASDAQ:STTK) Sees Significant Drop in Short Interest - MarketBeat
Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Stockholders to Inquire about Securities Investigation - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Investors to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Stockholders to Connect - AccessWire
STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - PR Newswire
Shattuck Labs, Inc. (STTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
Shattuck Labs Inc [STTK] Investment Guide: What You Need to Know - Knox Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Investors to Inquire about Securities Investigation - AccessWire
Marshall Wace LLP Sells 8,453 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Layoff Tracker: Medtronic, CareFusion Laying Off Over 400 Combined Employees - BioSpace
Shattuck Labs Inc [STTK] Shares Rise 11.11 % on Wednesday - Knox Daily
GXO Logistics, Momentus, Shattuck Labs: 3 Stocks Retail Investors Are Most Bullish On Today - Barchart
There is no doubt that Shattuck Labs Inc (STTK) ticks all the boxes. - SETE News
Shattuck Labs CEO buys $44.2k in company shares - Investing.com India
Shattuck Labs, Inc. (NASDAQ:STTK) CEO Taylor Schreiber Purchases 36,500 Shares - MarketBeat
How did Shattuck Labs Inc (STTK) fare last session? - US Post News
Shattuck Labs CEO buys $44.2k in company shares By Investing.com - Investing.com Canada
After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK) - Yahoo Finance
Shattuck Labs stock hits 52-week low at $1.15 amid market challenges - Investing.com Canada
Shattuck Labs stock hits 52-week low at $1.15 amid market challenges By Investing.com - Investing.com South Africa
Investing in Shattuck Labs Inc (STTK) Is Getting More Attractive - Knox Daily
Shattuck Labs Inc’s Shares Reel: -65.63% Quarterly Revenue Decline Amid 58.23M Market Cap - The InvestChronicle
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Brous Tyler | Director |
Jun 27 '24 |
Buy |
3.89 |
5,416 |
21,068 |
235,088 |
| Brous Tyler | Director |
Jun 28 '24 |
Buy |
3.90 |
3,000 |
11,700 |
238,088 |
| Schreiber Taylor | Chief Executive Officer |
Jun 26 '24 |
Buy |
3.47 |
14,400 |
50,011 |
34,502 |
| Schreiber Taylor | Chief Executive Officer |
Jun 04 '24 |
Option Exercise |
3.57 |
3,050 |
10,888 |
20,102 |
| Stout Stephen | See Remarks |
Mar 06 '24 |
Option Exercise |
3.54 |
11,109 |
39,380 |
85,791 |
| Stout Stephen | See Remarks |
Mar 06 '24 |
Sale |
10.53 |
16,004 |
168,522 |
74,437 |
| Neill Andrew R | Chief Financial Officer |
Jan 10 '24 |
Sale |
10.00 |
25,000 |
250,000 |
173,446 |
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):